Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

Stock Information for Accelerate Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Accelerate Diagnostics Inc.

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
Accelerate Diagnostics Announces Collaboration for the Use of the Arc(TM) System in Combination With Bruker´s MALDI Biotyper®
Accelerate Diagnostics Reports Third Quarter 2023 Results
Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.